CSL Limited
CSL Limited engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment manufactures, markets, and distributes plasma produ… Read more
CSL Limited (CMXHF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2025: 0.065x
Based on the latest financial reports, CSL Limited (CMXHF) has a cash flow conversion efficiency ratio of 0.065x as of December 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($1.33 Billion) by net assets ($20.47 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
CSL Limited - Cash Flow Conversion Efficiency Trend (1993–2025)
This chart illustrates how CSL Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
CSL Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of CSL Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Elevance Health Inc
NYSE:ELV
|
0.002x |
|
Nike Inc
NYSE:NKE
|
0.041x |
|
Meituan
PINK:MPNGF
|
0.029x |
|
Cencora Inc.
NYSE:COR
|
-1.100x |
|
Intel Corp. CEDEAR
BA:INTC
|
0.034x |
|
Wheaton Precious Metals Corp
NYSE:WPM
|
0.047x |
|
TC Energy Corp
NYSE:TRP
|
0.051x |
|
Tokio Marine Holdings Inc
PINK:TKOMY
|
0.021x |
Annual Cash Flow Conversion Efficiency for CSL Limited (1993–2025)
The table below shows the annual cash flow conversion efficiency of CSL Limited from 1993 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | $21.41 Billion | $3.56 Billion | 0.166x | +16.76% |
| 2024-06-30 | $19.40 Billion | $2.76 Billion | 0.142x | -2.36% |
| 2023-06-30 | $17.83 Billion | $2.60 Billion | 0.146x | -19.09% |
| 2022-06-30 | $14.58 Billion | $2.63 Billion | 0.180x | -68.67% |
| 2021-06-30 | $6.29 Billion | $3.62 Billion | 0.576x | +4.62% |
| 2020-06-30 | $4.52 Billion | $2.49 Billion | 0.550x | +22.82% |
| 2019-06-30 | $3.67 Billion | $1.64 Billion | 0.448x | -3.92% |
| 2018-06-30 | $3.00 Billion | $1.40 Billion | 0.466x | -8.99% |
| 2017-06-30 | $2.42 Billion | $1.24 Billion | 0.512x | -17.14% |
| 2016-06-30 | $1.92 Billion | $1.18 Billion | 0.618x | -4.35% |
| 2015-06-30 | $2.09 Billion | $1.35 Billion | 0.646x | +41.49% |
| 2014-06-30 | $2.97 Billion | $1.36 Billion | 0.457x | -2.87% |
| 2013-06-30 | $2.78 Billion | $1.31 Billion | 0.470x | +42.26% |
| 2012-06-30 | $3.55 Billion | $1.17 Billion | 0.331x | +26.49% |
| 2011-06-30 | $4.17 Billion | $1.09 Billion | 0.261x | -19.86% |
| 2010-06-30 | $3.02 Billion | $984.78 Million | 0.326x | +40.32% |
| 2009-06-30 | $3.52 Billion | $819.29 Million | 0.232x | -12.76% |
| 2008-06-30 | $2.58 Billion | $686.77 Million | 0.266x | +6.63% |
| 2007-06-30 | $1.63 Billion | $407.51 Million | 0.250x | -29.34% |
| 2006-06-30 | $1.09 Billion | $385.40 Million | 0.354x | -1.48% |
| 2005-06-30 | $1.20 Billion | $430.00 Million | 0.359x | +151.47% |
| 2004-06-30 | $1.02 Billion | $145.66 Million | 0.143x | -21.35% |
| 2002-06-30 | $404.62 Million | $73.43 Million | 0.181x | -37.13% |
| 2001-06-30 | $229.78 Million | $66.33 Million | 0.289x | +36.50% |
| 1997-06-30 | $205.15 Million | $43.38 Million | 0.211x | -0.16% |
| 1996-06-30 | $212.25 Million | $44.96 Million | 0.212x | +20.46% |
| 1995-06-30 | $167.67 Million | $29.48 Million | 0.176x | +6.01% |
| 1994-06-30 | $168.42 Million | $27.94 Million | 0.166x | +19.20% |
| 1993-06-30 | $70.25 Million | $9.78 Million | 0.139x | -- |